Gazyva 1000mg Solution for Infusion

About this Medicine

Gazyva 1000mg Solution for Infusion is used in the treatment of blood cancer (chronic lymphocytic leukemia). It binds to the receptors on cancer cells. Thus, it flags the cancer cells for destruction by the body's immune system. Gazyva 1000mg Solution for Infusion is given as an injection into the veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. Take it exactly as advised by the doctor. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include nasopharyngitis (inflammation of the throat and nasal passages), upper respiratory tract infection, rash, flu, dermatitis, and eczema. Let your doctor know if any of these side effects bother you or persist for longer. Regular blood tests are required to check your blood cell count and the heart, liver, and kidney functions.Before taking Gazyva 1000mg Solution for Infusion, tell your doctor if you have heart disease, liver or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine, so let your doctor know about all the medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during the treatment is important to avoid pregnancy.There is a Patient Support Program / Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

How it Works

Gazyva 1000mg Solution for Infusion works by recognizing and attaching to specific proteins (namely CD20) on leukemia cells and some healthy blood cells. It destroys leukemia cells directly or with the help of the immune system.

Key Facts

Chemical Class :: Peptides|Habit Forming :: No|Therapeutic Class :: ANTI NEOPLASTICS|Action Class :: Monoclonal antibodies

Safety Overview